Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Innate Pharma (OTCMKTS:IPHYF – Get Free Report) and Bio-Techne (NASDAQ:TECH – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, dividends, profitability and analyst recommendations. Risk & Volatility Innate Pharma has a beta of […]
Inceptionr LLC purchased a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 27,715 shares of the biotechnology company’s stock, valued at approximately $2,056,000. Bio-Techne accounts for about 0.7% of Inceptionr LLC’s portfolio, making […]
Blair William & Co. IL lifted its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.3% during the 1st quarter, Holdings Channel reports. The fund owned 114,661 shares of the biotechnology company’s stock after acquiring an additional 353 shares during the quarter. Blair William & Co. IL’s holdings in Bio-Techne were worth $8,507,000 at […]
William Blair began coverage on shares of Bio-Techne (NASDAQ:TECH – Free Report) in a research report released on Monday morning, MarketBeat reports. The firm issued an outperform rating on the biotechnology company’s stock. William Blair also issued estimates for Bio-Techne’s Q1 2024 earnings at $0.40 EPS, Q2 2024 earnings at $0.40 EPS, Q3 2024 earnings […]
Itau Unibanco Holding S.A. boosted its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 322.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,621 shares of the biotechnology company’s stock after acquiring an additional 5,052 shares during the period. […]